6,534 followers
New research: Cost-Effectiveness Analysis of Fourth- or Further-Line Ripretinib in Advanced Gastrointestinal Stromal Tumors: Background The INVICTUS trial assessed the efficacy and safety of ripretinib compared with placebo in the management of… https://t.